EUVIMEDEUVIMED entdecken
Crossref

Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis

Rong Hua, Hong-Fei Yao, Zi-Yu Song, Feng Yu, Zhao-Yu Che, Xiao-Fang Gao, Yan-Miao Huo, Wei Liu, Yong-Wei Sun, Min-Wei Yang, Jian-Yu Yang, Shan Zhang und 1 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Rong Hua und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplasm Invasiveness. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nerve invasion (NI) is a characteristic feature of pancreatic cancer. Traditional dichotomous statements on the presence of NI are unreasonable because almost all cases exhibit NI when sufficient pathological sections are examined. The critical implications of NI in pancreatic cancer highlight the need for a more effective criterion. This study included 511 patients, who were categorized into a training group and a testing group at a ratio of 7:3. According to the traditional definition, NI was observed in 91.2 % of patients using five pathological slides in our study. The prevalence of NI increased as more pathological slides were used. The criterion of 'two points of intraneural (endoneural) invasion in the case of four pathological slides' has the highest receiver operating characteristic (ROC) score. Based on this new criterion, NI was proved to be an independent prognostic factor for overall survival (OS) and disease-free survival (DFS) and was also correlated with tumor recurrence (P = 0.004). Interestingly, gemcitabine-based chemotherapy regimen is an independent favorable factor for patients with high NI. In the high NI group, patients who received a gemcitabine-based regimen exhibited a better prognosis than those who did not receive the gemcitabine-based regimen for OS (P = 0.000) and DFS (P = 0.001). In conclusion, this study establishes assessment criteria to evaluate the severity of NI in order to predict patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeoplasm InvasivenessHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultDisease-Free SurvivalDeoxycytidineGemcitabineROC CurveAged, 80 and overPrognosis

Stichwörter der Autor:innen

Endoneural invasionIntraneural invasionNerve invasionPancreatic ductal adenocarcinomaPerineural invasion

Substanzen

DeoxycytidineGemcitabine

Autor:innen und Institutionen

  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China.
  • Department of Hepato-Biliary-Pancreatic Surgery, General Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, PR China.
  • Department of Pathology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China.
  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China. Electronic address: yangmw90@163.com.
  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China. Electronic address: 18817821432@126.com.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, PR China. Electronic address: zhangs0049@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hua, R., Yao, H. F., Song, Z. Y., Yu, F., Che, Z. Y., Gao, X. F., Huo, Y. M., Liu, W., Sun, Y. W., Yang, M. W., Yang, J. Y., Zhang, S., & Zhang, J. F. (2024). Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217213

Vancouver

Hua R, Yao HF, Song ZY, Yu F, Che ZY, Gao XF, et al. Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217213

BibTeX
@article{Hua2024,
  author = {Hua, Rong and Yao, Hong-Fei and Song, Zi-Yu and Yu, Feng and Che, Zhao-Yu and Gao, Xiao-Fang and Huo, Yan-Miao and Liu, Wei and Sun, Yong-Wei and Yang, Min-Wei and Yang, Jian-Yu and Zhang, Shan and Zhang, Jun-Feng},
  title = {Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217213}
}
Kostenlos starten →